Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients After Surgery

Overview

Journal Rev Recent Clin Trials

Specialties General Medicine
Pharmacology

Date 2022 Aug 12

PMID 35959618

Authors

Francesca Di Candido

Affiliations

Soon will be listed here.

Abstract

Inflammatory Bowel Diseases (IBDs) are chronic, relapsing and disabling diseases that affect the gastrointestinal tract. This relapsing course is often unpredictable with severe flares and the need for intensive medical treatment, hospitalization, or emergent/urgent surgery, all of which significantly impact patients' quality of life (QoL). QoL in IBD patients is significantly lower than in the general population, and depression and anxiety have been shown to have a higher prevalence than in healthy individuals, especially during disease flares. Complications requiring hospitalization and repeated surgeries are not uncommon during the disease course and significantly affect QoL in IBD patients. Patient-reported outcome measures (PROMs) can be used to measure the impact of chronic disease on QoL from the patient's perspective. The use of PROMs in IBD patients undergoing surgery could help to investigate the impact of the surgical procedure on QoL and determine whether there is any improvement or worsening. This review summarizes the use of PROMs to assess QoL after various surgical procedures required for IBD treatment.

Citing Articles

Saffron as a Promising Therapy for Inflammatory Bowel Disease.

Rashid M, Rashid R, Saroya S, Deverapalli M, Brim H, Ashktorab H Nutrients. 2024; 16(14).

PMID: 39064796 PMC: 11280066. DOI: 10.3390/nu16142353.

Surgical treatment of inflammatory bowel disease: From the gastroenterologist's stand-point.

Triantafillidis J World J Gastrointest Surg. 2024; 16(5):1235-1254.

PMID: 38817292 PMC: 11135302. DOI: 10.4240/wjgs.v16.i5.1235.

References

Burisch J, Munkholm P . The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015; 50(8):942-51. DOI: 10.3109/00365521.2015.1014407. View

Levine J, Burakoff R . Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011; 7(4):235-41. PMC: 3127025. View

Simian D, Quijada M, Lubascher J, Acuna R, Quera R . [Treatment of inflammatory bowel disease with infliximab: experience in 25 patients]. Rev Med Chil. 2014; 141(9):1158-65. DOI: 10.4067/S0034-98872013000900008. View

Cohen R . The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther. 2002; 16(9):1603-9. DOI: 10.1046/j.1365-2036.2002.01323.x. View

Rogala L, Miller N, Graff L, Rawsthorne P, Clara I, Walker J . Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14(4):526-35. DOI: 10.1002/ibd.20353. View

LeBlanc K, Mosli M, Parker C, MacDonald J . The impact of biological interventions for ulcerative colitis on health-related quality of life. Cochrane Database Syst Rev. 2015; (9):CD008655. PMC: 9235035. DOI: 10.1002/14651858.CD008655.pub3. View

Ghosh S, Mitchell R . Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2010; 1(1):10-20. DOI: 10.1016/j.crohns.2007.06.005. View

Filipovic B, Filipovic B . Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol. 2014; 20(13):3552-63. PMC: 3974522. DOI: 10.3748/wjg.v20.i13.3552. View

Hauser W, Janke K, Klump B, Hinz A . Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis. 2010; 17(2):621-32. DOI: 10.1002/ibd.21346. View

10.

Graff L, Walker J, Bernstein C . Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009; 15(7):1105-18. DOI: 10.1002/ibd.20873. View

11.

Bernstein C, Singh S, Graff L, Walker J, Miller N, Cheang M . A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010; 105(9):1994-2002. DOI: 10.1038/ajg.2010.140. View

12.

Barnes E, Kochar B, Long M, Kappelman M, Martin C, Korzenik J . Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis. 2017; 23(6):875-881. PMC: 5512697. DOI: 10.1097/MIB.0000000000001121. View

13.

Ananthakrishnan A, Gainer V, Perez R, Cai T, Cheng S, Savova G . Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther. 2013; 37(4):445-54. PMC: 3552092. DOI: 10.1111/apt.12195. View

14.

Best W, Becktel J, SINGLETON J, KERN Jr F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. View

15.

Harvey R, Bradshaw J . A simple index of Crohn's-disease activity. Lancet. 1980; 1(8167):514. DOI: 10.1016/s0140-6736(80)92767-1. View

16.

Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R . Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011; 60(5):571-607. DOI: 10.1136/gut.2010.224154. View

17.

Beddy D, Dozois E, Pemberton J . Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis. 2011; 17(7):1610-9. DOI: 10.1002/ibd.21504. View

18.

Allison M, Lindsay J, Gould D, Kelly D . Surgery in young adults with inflammatory bowel disease: a narrative account. Int J Nurs Stud. 2013; 50(11):1566-75. DOI: 10.1016/j.ijnurstu.2013.04.003. View

19.

Hahnloser D, Pemberton J, Wolff B, Larson D, Crownhart B, Dozois R . Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007; 94(3):333-40. DOI: 10.1002/bjs.5464. View

20.

Porter M . What is value in health care?. N Engl J Med. 2010; 363(26):2477-81. DOI: 10.1056/NEJMp1011024. View